183 related articles for article (PubMed ID: 8012722)
1. [125I]-PD151242: a selective radioligand for human ETA receptors.
Davenport AP; Kuc RE; Fitzgerald F; Maguire JJ; Berryman K; Doherty AM
Br J Pharmacol; 1994 Jan; 111(1):4-6. PubMed ID: 8012722
[TBL] [Abstract][Full Text] [Related]
2. Endothelin receptors in human coronary artery and aorta.
Bacon CR; Davenport AP
Br J Pharmacol; 1996 Mar; 117(5):986-92. PubMed ID: 8851522
[TBL] [Abstract][Full Text] [Related]
3. Selectivity of [125I]-PD151242 for human, rat and porcine endothelin ETA receptors in the heart.
Peter MG; Davenport AP
Br J Pharmacol; 1995 Jan; 114(2):297-302. PubMed ID: 7881728
[TBL] [Abstract][Full Text] [Related]
4. [125I]-PD151242: a selective ligand for endothelin ETA receptors in human kidney which localizes to renal vasculature.
Davenport AP; Kuc RE; Hoskins SL; Karet FE; Fitzgerald F
Br J Pharmacol; 1994 Dec; 113(4):1303-10. PubMed ID: 7534185
[TBL] [Abstract][Full Text] [Related]
5. ETA and ETB endothelin receptors in human myometrium characterized by the subtype selective ligands BQ123, BQ3020, FR139317 and PD151242.
Bacon CR; Morrison JJ; O'Reilly G; Cameron IT; Davenport AP
J Endocrinol; 1995 Jan; 144(1):127-34. PubMed ID: 7891013
[TBL] [Abstract][Full Text] [Related]
6. Characterization of [125I]-PD164333, an ETA selective non-peptide radiolabelled antagonist, in normal and diseased human tissues.
Davenport AP; Kuc RE; Ashby MJ; Patt WC; Doherty AM
Br J Pharmacol; 1998 Jan; 123(2):223-30. PubMed ID: 9489609
[TBL] [Abstract][Full Text] [Related]
7. Characterization of endothelin receptors in human brain cortex, gliomas, and meningiomas.
Harland SP; Kuc RE; Pickard JD; Davenport AP
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S408-11. PubMed ID: 8587429
[TBL] [Abstract][Full Text] [Related]
8. Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type.
Davenport AP; O'Reilly G; Kuc RE
Br J Pharmacol; 1995 Mar; 114(6):1110-6. PubMed ID: 7620699
[TBL] [Abstract][Full Text] [Related]
9. Endothelin ETA receptor expression in human cerebrovascular smooth muscle cells.
Yu JC; Pickard JD; Davenport AP
Br J Pharmacol; 1995 Nov; 116(5):2441-6. PubMed ID: 8581282
[TBL] [Abstract][Full Text] [Related]
10. Human endothelin receptors characterized using reverse transcriptase-polymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle.
Davenport AP; O'Reilly G; Molenaar P; Maguire JJ; Kuc RE; Sharkey A; Bacon CR; Ferro A
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S22-5. PubMed ID: 7509950
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the binding of endothelin ETB selective ligands in human and rat heart.
Russell FD; Davenport AP
Br J Pharmacol; 1996 Oct; 119(4):631-6. PubMed ID: 8904635
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: possible formation of an ETA-ETB receptor heterodimer.
Harada N; Himeno A; Shigematsu K; Sumikawa K; Niwa M
Cell Mol Neurobiol; 2002 Apr; 22(2):207-26. PubMed ID: 12363203
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart.
Peter MG; Davenport AP
Br J Pharmacol; 1996 Feb; 117(3):455-462. PubMed ID: 8821534
[TBL] [Abstract][Full Text] [Related]
14. Characterization of [125I]-endothelin-1 and [125I]-BQ3020 binding to rat cerebellar endothelin receptors.
Widdowson PS; Kirk CN
Br J Pharmacol; 1996 Aug; 118(8):2126-30. PubMed ID: 8864551
[TBL] [Abstract][Full Text] [Related]
15. Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart.
Molenaar P; Kuc RE; Davenport AP
Br J Pharmacol; 1992 Nov; 107(3):637-9. PubMed ID: 1472961
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of the rat cerebellar endothelin B (ETB) receptor using the novel agonist radioligand [125I]BQ3020.
Jarvis MF; Assal AA; Gessner G
Brain Res; 1994 Nov; 665(1):33-8. PubMed ID: 7882015
[TBL] [Abstract][Full Text] [Related]
17. High affinity interaction of endothelin-3 with recombinant ETA receptors.
Desmarets J; Frelin C
Biochem Biophys Res Commun; 1999 Mar; 256(2):357-60. PubMed ID: 10079188
[TBL] [Abstract][Full Text] [Related]
18. [3H]BQ-123, a highly specific and reversible radioligand for the endothelin ETA receptor subtype.
Ihara M; Yamanaka R; Ohwaki K; Ozaki S; Fukami T; Ishikawa K; Towers P; Yano M
Eur J Pharmacol; 1995 Feb; 274(1-3):1-6. PubMed ID: 7768260
[TBL] [Abstract][Full Text] [Related]
19. Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney.
Karet FE; Kuc RE; Davenport AP
Kidney Int; 1993 Jul; 44(1):36-42. PubMed ID: 8355464
[TBL] [Abstract][Full Text] [Related]
20. Characterization of peptide and nonpeptide antagonists in human kidney.
Kuc RE; Karet FE; Davenport AP
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S373-5. PubMed ID: 8587419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]